Abstract:Background and aims: Effective hepatic blood flow (EHBF) decreases with liver disease progression, and identifying liver pathology is critical for patients with liver disease. This study was designed to elucidate the correlation between EHBF and liver pathology and explore the potential of EHBF for predicting the degree of liver pathology. Methods: In this study, 207 patients with hepatitis B virus (HBV) who underwent liver biopsy and indocyanine green (ICG) clearance tests were enrolled. EHBF was measured using the ICG clearance test, and liver tissue was histologically analyzed to determine the pathological stage according to the Scheuer scoring system. Demographic data, biochemical indexes, and FibroScan data were collected for statistical analysis. Results: EHBF levels decreased as the liver histological stages of inflammation and fibrosis increased (P < 0.01). EHBF was significantly negatively associated with the levels of alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transpeptidase, alkaline phosphatase, aspartate aminotransferase-to-platelet ratio index, fibrosis index based on the four factors, and liver stiffness measurement (P < 0.05). The EHBF levels of patients without liver inflammation (G0) were significantly higher than those of patients with liver inflammation (G1-4) (P < 0.001). The area under the receiver operating characteristic curve (AUROC) value for discriminating patients without liver inflammation was 0.827, and the optimal cutoff value was 0.936 L/min. The EHBF levels of patients with severe liver inflammation (G4) were significantly lower than those of patients with G0-3 liver inflammation (P < 0.001). The AUROC value for discriminating patients with severe liver inflammation was 0.792, and the optimal cutoff value was 0.552 L/min. The EHBF levels of patients without liver fibrosis (S0) were significantly higher than those of patients with liver fibrosis (S1-4) (P < 0.001). The AUROC value for discriminating patients without liver fibrosis was 0.633, and the optimal cutoff value was 1.173 L/min. The EHBF levels of patients with liver cirrhosis (S4) were significantly lower than those of patients with S0-3 liver fibrosis (P < 0.001). The AUROC value for discriminating patients with liver cirrhosis (S4) was 0.630, and the optimal cutoff value was 0.562 L/min. Conclusions: EHBF levels and liver pathology are significantly correlated. EHBF could effectively reflect liver inflammation and fibrosis in patients infected with HBV, especially for patients without liver inflammation or liver fibrosis. (c) 2021 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B. V. on behalf of KeAi Communications Co., Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Relationship Between Cutaneous Electrogastrogram Parameters and Impairment of Liver Function in Patients with Liver Cirrhosis

Plasma levels of ascorbic acid and vitamin E in patients with liver cirrhosis

Clinical Significance of the Serum Neopterin Detection in Patients with Liver Cirrhosis

Characterization of the Gastric Mucosal Microbiota in Patients with Liver Cirrhosis and Its Associations with Gastrointestinal Symptoms

Characterization of Fecal Microbial Communities in Patients with Liver Cirrhosis.

Correlation Analysis on Nonalcoholic Simple Fatty Liver and Estimated Glomerular Filtration Rate

Functional gene arrays-based analysis of fecal microbiomes in patients with liver cirrhosis

The relationship between platelet count to spleen sizes ratio,serum-ascites album gradient and esophageal varices in liver cirrhosis

Comparison of the Gut Microbe Profiles and Numbers Between Patients with Liver Cirrhosis and Healthy Individuals

Evaluation of Quantitative and Selective Sensory Fiber Dysfunction in Patients with Cirrhosis

Study on the Relationship between Phospholipids and Nonalcoholic Fatty Liver Disease

Determination of plasma β-carotene in patients with liver cirrhosis and its significance

Correlation between hepatic venous pressure gradient and clinic features in patients with liver cirrhosis

Relationship between plasma homocysteine and alcoholic liver cirrhosis

The Study on Cardiac Function of Liver Cirrhosis Patients

Expression of GP73 in Liver Cirrhosis and Its Assistant Value in Grading of Liver Cirrhosis

Correlation of Effective Hepatic Blood Flow with Liver Pathology in Patients with Hepatitis B Virus

Psychometric Hepatic Encephalopathy Tests and Electroencephalogram Results Among Cirrhotic Patients

Upper Gastrointestinal Endoscopic Findings and Their Clinical Correlates in Patients With Liver Cirrhosis in Northern Ghana

Assessing Liver Fibrosis in Chronic Hepatitis B Using MR Extracellular Volume Measurements: Comparison with Serum Fibrosis Indices

Preliminary Study on the Evaluation of Liver Fibrosis Using Endoscopic Ultrasound Elastography and Transabdominal Ultrasound Transient Elastography Combined with Strain Ratio